How best to manage patients with chronic lymphocytic leuekmia with 17p deletion and/or TP53 mutation?
about
Serum LDH level may predict outcome of chronic lymphocytic leukemia patients with a 17p deletion: a retrospective analysis of prognostic factors in China.The impact of TP53 mutations and TP53 deletions on survival varies between AML, ALL, MDS and CLL: an analysis of 3307 cases.Highlights in the treatment of chronic lymphocytic leukemia from the 2014 meeting of the American Society of Hematology.CLL: ibrutinib and transplantation ride together.
P2860
How best to manage patients with chronic lymphocytic leuekmia with 17p deletion and/or TP53 mutation?
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年学术文章
@wuu
2015年学术文章
@zh-cn
2015年学术文章
@zh-hans
2015年学术文章
@zh-my
2015年学术文章
@zh-sg
2015年學術文章
@yue
2015年學術文章
@zh
2015年學術文章
@zh-hant
name
How best to manage patients wi ...... deletion and/or TP53 mutation?
@en
type
label
How best to manage patients wi ...... deletion and/or TP53 mutation?
@en
prefLabel
How best to manage patients wi ...... deletion and/or TP53 mutation?
@en
P2860
P1433
P1476
How best to manage patients wi ...... deletion and/or TP53 mutation?
@en
P2093
Constantine S Tam
P2860
P304
P356
10.3109/10428194.2015.1011641
P577
2015-02-17T00:00:00Z